{"id":2577,"date":"2026-08-27T06:40:15","date_gmt":"2026-08-27T06:40:15","guid":{"rendered":"https:\/\/www.stemcellcure.in\/blog\/?p=2577"},"modified":"2026-09-09T06:43:07","modified_gmt":"2026-09-09T06:43:07","slug":"retinitis-pigmentosa-treatment-in-india","status":"publish","type":"post","link":"https:\/\/www.stemcellcure.in\/blog\/retinitis-pigmentosa-treatment-in-india\/","title":{"rendered":"Retinitis Pigmentosa Treatment in India"},"content":{"rendered":"

Medically reviewed by Dr. Prashant Tyagi (Stem Cell Biotechnology Specialist, 10+ years) and Dr. Pallavee Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience<\/em><\/strong><\/p>\n

Retinitis pigmentosa (RP) patients researching treatment options frequently come across stem cell therapy offered in India, given the country’s growing regenerative medicine sector and comparatively lower treatment costs. Here’s an honest look at what this treatment actually involves, and what patients should genuinely understand before pursuing it.<\/p>\n

Why RP Is Being Studied for Stem Cell Approaches<\/h2>\n

RP involves the progressive loss of photoreceptor cells – rods and cones – in the retina, caused by mutations in any of more than 80 identified genes. Stem cell research in this area generally explores whether specific approaches can support the health of remaining viable photoreceptor cells, slow further degeneration, or in some studied applications, support the surrounding retinal environment – rather than fully regenerating photoreceptor cells that have already been lost.<\/p>\n

Why Genetic Diagnosis Matters Before Considering Treatment<\/h2>\n

Because RP encompasses many different genetic subtypes with varying rates of progression, a confirmed genetic diagnosis is an important step before any treatment discussion. Understanding the specific gene involved helps clarify disease stage, likely progression pattern, and how much viable retinal tissue may remain – all factors that meaningfully affect whether stem cell therapy is a reasonable option for a specific patient’s case.<\/p>\n

What the Treatment Process Typically Involves<\/h2>\n

For most patients, particularly those travelling from abroad, the process generally begins with remote review of medical reports, genetic testing results where available, and retinal imaging, allowing specialists to provide an honest assessment of candidacy before travel is arranged. This is usually followed by an in-person evaluation, the treatment procedure, and a defined period of monitoring, with longer-term follow-up coordinated with the patient’s local eye doctor.<\/p>\n

What Current Evidence Actually Supports<\/h2>\n

It’s important to be direct here: stem cell therapy for RP remains an evolving area of medicine, with evidence continuing to develop across different genetic subtypes and disease stages. Responsible providers describe realistic outcomes as potentially including stabilisation of remaining function or modest improvement in select cases, rather than promising restoration of vision already lost to advanced photoreceptor degeneration.<\/p>\n

Regulatory Standards Worth Understanding<\/h2>\n

India’s regulatory framework allows a broader range of stem cell applications to be offered as medical treatment following individual case evaluation, while requiring ethical sourcing and laboratory accreditation. Patients evaluating providers should ask specifically about laboratory accreditation and how the clinic’s practice aligns with India’s National Guidelines for Stem Cell Research, rather than assuming uniform standards across all providers.<\/p>\n

Questions Worth Asking Before Choosing a Provider<\/h2>\n